Delivery Order SPE2DB20D1100-SPE2DB25FD7R3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,834.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,994.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitive award, with no set-aside designation, is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $26,079.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,441.80 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $10,019.57 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml units). This competitively awarded, firm fixed-price contract will be completed by July 21, 2025, with performance taking place at the vendor's Corporate Office in Conshohocken, Pennsylvania. The award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $9,777.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pens with a completion date of July 22, 2025. This is a competitively awarded, non-set-aside contract with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single requisition fulfillment under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,448.81 on July 21, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, to be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. As a child contract action, this delivery order falls under AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7R3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens valued at $2,614.05. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime contract running through December 2026 that serves as a comprehensive pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to the Defense Logistics Agency and federal healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Mounjaro, a diabetes medication, exemplifies the company's role in supplying specialty pharmaceuticals to support military and veteran healthcare needs through the DLA's medical supply chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/31/25 |